Skip to main content
. 2021 Nov 11;8(11):1040. doi: 10.3390/children8111040

Table 3.

Clinical Summaries of Patients with CMV Infections Who Developed Epilepsy or ASD.

Patient No. Sex/Labor Age of CMV INF Type of Infection Antiviral Treatment MR Epilepsy/
Age of Dx
ASD/
Age of Dx
Last EEG Patterns/Age Number of AED Uses Seizure Control/Freq Brain MRI
CMV01 F/P 0 Congenital GCV S +/1 y - H yps/2 y 4 Unfavorable WM
CMV02 M/T 0 Congenital GCV M to S +/1 y +/3 y Multi/5 y 1 Controlled VM
CMV03 M/T 0 Congenital GCV M +/1 y +/2 y Multi/2 y 1 Controlled HCP
CMV04 F/T 0 Congenital GCV S +/1 y - Multi/3 y 1 Controlled HCP
CMV05 M/T 0 E/P - - +/2 y - Normal/9 y 1 Controlled Normal
CMV06 M/T 1.5 y Immunocompetent - - +/2 y - Normal/8 y 0 Yearly Normal
CMV07 F/T 1 y Immunocompetent - M to S +/1 y - Multi/2 y 2 Monthly WM
CMV08 F/P 0 Congenital GCV Mild - +/3 y N/A N/A N/A Normal
CMV09 F/T 2.1 y Immunocompetent - - - +/3 y N/A N/A N/A Normal

M, male; F, female; AED, Antiepileptic drug; E/P, Early postnatal; Dx, diagnosis; EEG, Electroencephalography; Freq, frequency; GCV, ganciclovir; +, present; -, not present; HCP, hydrocephalus; Hyps, hypsarrhythmia; INF, infection; MR, mental retardation; MRI, magnetic resonance imaging; M, moderate; Multi, multifocal spikes; N/A, not applicable; P, preterm; S, severe; T, term; VM, ventriculomegaly; WM, white matter lesions; y, years.